137 related articles for article (PubMed ID: 36595775)
1. Thermal ablation for cervical lymph node metastasis from papillary thyroid carcinoma: A meta-analysis.
Zhu Y; Wang Y; Liu F; Liao Y; Wang Q; Xiao X
Medicine (Baltimore); 2022 Dec; 101(51):e32193. PubMed ID: 36595775
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonography-Guided Thermal Ablation for Cervical Lymph Node Metastasis of Recurrent Papillary Thyroid Carcinoma: Is it Superior to Surgical Resection?
Zhang X; Ni T; Zhang W
Front Endocrinol (Lausanne); 2022; 13():907195. PubMed ID: 35832431
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis.
Tang W; Tang X; Jiang D; Zhang X; Wang R; Niu X; Zang Y; Zhang M; Wang X; Zhao C
Front Endocrinol (Lausanne); 2022; 13():967044. PubMed ID: 36072932
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided thermal ablation for cervical lymph node metastasis from thyroid carcinoma: a meta-analysis of clinical efficacy and safety.
Qiu Y; Xing Z; He Y; Liu J; Yang Q; Luo Y
Lasers Med Sci; 2022 Apr; 37(3):1747-1754. PubMed ID: 34617202
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency Ablation for Cervical Metastatic Lymph Nodes in Children and Adolescents With Papillary Thyroid Carcinoma: A Preliminary Study.
Yan L; Zhang Y; Jiang B; Luo Y
Front Endocrinol (Lausanne); 2021; 12():624054. PubMed ID: 34084150
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma.
Han ZY; Dou JP; Cheng ZG; Liu FY; Yu J; Yu XL; Liang P
Int J Hyperthermia; 2020; 37(1):971-975. PubMed ID: 32781871
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
Zhao L; Wu F; Zhou T; Lu K; Jiang K; Zhang Y; Luo D
Endocrine; 2022 Feb; 75(2):351-359. PubMed ID: 35067901
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the safety and efficacy of microwave ablation in treatment of cervical metastatic lymph nodes of papillary thyroid carcinoma compared to repeat surgery.
Tang W; Sun W; Niu X; Wang X; Wang X; Zhang M; Wang R; Jiang W; Jiang D; Zhao C
Int J Hyperthermia; 2022; 39(1):813-821. PubMed ID: 35719117
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Thermal Ablation for Treating Lymph Node Metastasis From Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Ding Z; Chen J; Chen Z; Zeng X; Zheng P; Wang X; Cui X; Sang L
Front Oncol; 2022; 12():738299. PubMed ID: 35433407
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous laser ablation of cervical metastatic lymph nodes in papillary thyroid carcinoma: clinical efficacy and anatomical considerations.
Spartalis E; Karagiannis SP; Plakopitis N; Theodori MA; Athanasiadis DI; Schizas D; Spartalis M; Troupis T
Expert Rev Med Devices; 2021 Jan; 18(1):75-82. PubMed ID: 33307870
[No Abstract] [Full Text] [Related]
13. Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.
Tan L; Ji J; Sharen G; Liu Y; Lv K
Front Endocrinol (Lausanne); 2022; 13():935559. PubMed ID: 36046785
[TBL] [Abstract][Full Text] [Related]
14. Over than three-year follow-up results of thermal ablation for papillary thyroid carcinoma: A systematic review and meta-analysis.
Xue J; Teng D; Wang H
Front Endocrinol (Lausanne); 2022; 13():971038. PubMed ID: 36353232
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma: A meta-analysis.
Yan B; Hou Y; Chen D; He J; Jiang Y
Int J Surg; 2018 Nov; 59():90-98. PubMed ID: 30342280
[TBL] [Abstract][Full Text] [Related]
16. Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma.
Zhou M; Duan Y; Ye B; Wang Y; Li H; Wu Y; Chen P; Zhu J; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2022; 13():914946. PubMed ID: 35923627
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
18. Clinical Efficacy of Intraoperative Ultrasound for Prophylactic Lymphadenectomy of the Lateral Cervical Neck in Stage CN0 Papillary Thyroid Cancer: A Prospective Study.
Shen Y; Li X; Tao L; Chen Y; Xie R
J Invest Surg; 2023 Dec; 36(1):2154416. PubMed ID: 36519315
[No Abstract] [Full Text] [Related]
19. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.
Ahn JH; Kwak JH; Yoon SG; Yi JW; Yu HW; Kwon H; Kim SJ; Lee KE
Surgery; 2022 Jan; 171(1):182-189. PubMed ID: 34391573
[TBL] [Abstract][Full Text] [Related]
20. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
